Ddd Partners, LLC Novo Nordisk A S Transaction History

Ddd Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$95.28 - $116.93 $17.8 Million - $21.8 Million	-186,535 Reduced 96.49%	6,787 $676,000
Q2 2022 Aug 03, 2022	BUY	$103.24 - $121.81 $199,459 - $235,336	1,932 Added 1.01%	193,322 $21.5 Million
Q1 2022 May 05, 2022	BUY	$93.1 - $112.54 $7.27 Million - $8.79 Million	78,095 Added 68.93%	191,390 $21.3 Million
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $10.9 Million - $13.3 Million	113,295 New	113,295 $12.7 Million

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Ddd Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ddd Partners, LLC with notifications on news.